In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Senseonics Holdings Inc. (NYSEMKT:SENS) reported that New Enterprise Associates 10 L P. has picked up 35,316,098 of common stock as of 2017-06-09.
The acquisition brings the aggregate amount owned by New Enterprise Associates 10 L P. to a total of 35,316,098 representing less than 28.2% stake in the company.
For those not familiar with the company, Senseonics Holdings, Inc. is a medical technology company. The Company focuses on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed an implantable CGM system designed to continually measure glucose levels in people with diabetes. The Company’s Eversense system consists of components, such as a sensor, which is inserted subcutaneously in the upper arm by a healthcare provider; an external removable smart transmitter that receives, assesses and relays the data from the sensor and also provides vibratory alerts, and a mobile application that receives data from the transmitter and provides real-time glucose readings, alerts and other data on the user’s mobile device, such as a smartphone, Apple Watch or tablet.
A glance at Senseonics Holdings Inc. (NYSEMKT:SENS)’s key stats reveals a current market capitalization of 192.30 Million based on 123.18 Million shares outstanding and a price at last close of $1.55 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-06-01, Barrett picked up 7,092,198 at a purchase price of $1.41. This brings their total holding to 21,911,183 as of the date of the filing.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Senseonics Holdings Inc. (NYSEMKT:SENS) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.